3Q7-98856-42055
1 vaccination
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 080 / NJ
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-12
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-10
- 2021-05-15
- 2021-05-22
- 2021-07-10
- 2021-10-09
-
2022-04-10
Survey response — 12 months, dose 1MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-10 | Unsuccessful |
Free text
Release 11 — 12 months, dose 1
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release